FRAMINGHAM, Mass., HeartWare International, Inc., a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, ...
DUBLIN -- Medtronic plc today announced two-year outcomes from the LATERAL clinical trial evaluating the use of its HeartWare™ HVAD™ System in patients who received the system via a less-invasive, ...
Thoracoscopic (VATS) lobectomy after a decade of criticism is nowadays considered as a technically feasible, safe and oncologically proper operation. This approach has some advantages over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results